119 related articles for article (PubMed ID: 24694342)
1. Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.
Zhao C; Li Z; Nayar R; Levi AW; Winkler BA; Moriarty AT; Barkan GA; Rao J; Miller F; Fan F; Zhou Z; Si Q; Fischer AH; Sturgis CD; Jing X; Marshall CB; Witt BL; Birdsong GG; Crothers BA
Arch Pathol Lab Med; 2015 Feb; 139(2):184-8. PubMed ID: 24694342
[TBL] [Abstract][Full Text] [Related]
2. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
3. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
4. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
5. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for recurrent cancers and vaginal epithelial lesions in patients with invasive cervical cancer after hysterectomy: are vaginal cytology and high-risk human papillomavirus testing useful?
Li Z; Barron S; Hong W; Karunamurthy A; Zhao C
Am J Clin Pathol; 2013 Nov; 140(5):708-14. PubMed ID: 24124151
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
8. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
[TBL] [Abstract][Full Text] [Related]
9. [Significance of human papillomavirus test in triage of patients with atypical squamous cell of undetermined significance].
Zhao J; Zhou JN; Yang YJ; Liao QP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):299-301. PubMed ID: 19105350
[TBL] [Abstract][Full Text] [Related]
10. [Value assessment of high-risk HPV test and TCT in the screening of cervical carcinoma].
Sun XF; Gu YQ; Wang AC; Wang J; Xie JL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):273-6. PubMed ID: 24579473
[TBL] [Abstract][Full Text] [Related]
11. Changes over time in papanicolaou cytology test and HPV test in a large women's academic center laboratory.
Jones TE; Matsko J; Elishaev E; Clark BZ; Carter G; Harinath L; Zhao C
J Am Soc Cytopathol; 2023; 12(4):307-313. PubMed ID: 37142542
[TBL] [Abstract][Full Text] [Related]
12. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
Zhao C; Li Z; Austin RM
Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
[TBL] [Abstract][Full Text] [Related]
13. Molecular testing of human papillomavirus in cervical specimens.
Gazzaz FB
Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
[TBL] [Abstract][Full Text] [Related]
14. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
17. Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution.
Patadji S; Li Z; Pradhan D; Zhao C
Cancer Cytopathol; 2017 Mar; 125(3):205-211. PubMed ID: 28060456
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
19. The clinical performance of computer-assisted liquid-based cytology, primary hrHPV screening, and cotesting at a Turkish Tertiary Care Hospital.
Kir G; Seneldir H; Cosan Sarbay B
Diagn Cytopathol; 2018 Jan; 46(1):3-8. PubMed ID: 29024512
[TBL] [Abstract][Full Text] [Related]
20. Review of Cytology Practice at Thomas Jefferson University Hospital before and after High-Risk Human Papillomavirus Testing.
Bibbo M; Wang ZX; Jones K; Solomides C; Draganova-Tacheva R; Stapp R
Acta Cytol; 2016; 60(6):534-539. PubMed ID: 27245463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
